Peter A. McCullough

60.4k total citations · 12 hit papers
612 papers, 37.0k citations indexed

About

Peter A. McCullough is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Surgery. According to data from OpenAlex, Peter A. McCullough has authored 612 papers receiving a total of 37.0k indexed citations (citations by other indexed papers that have themselves been cited), including 300 papers in Cardiology and Cardiovascular Medicine, 211 papers in Nephrology and 116 papers in Surgery. Recurrent topics in Peter A. McCullough's work include Heart Failure Treatment and Management (130 papers), Chronic Kidney Disease and Diabetes (100 papers) and Dialysis and Renal Disease Management (90 papers). Peter A. McCullough is often cited by papers focused on Heart Failure Treatment and Management (130 papers), Chronic Kidney Disease and Diabetes (100 papers) and Dialysis and Renal Disease Management (90 papers). Peter A. McCullough collaborates with scholars based in United States, Italy and United Kingdom. Peter A. McCullough's co-authors include Keisha R. Sandberg, William W. O’Neill, Alan S. Maisel, Claudio Ronco, Richard M. Nowak, Judd E. Hollander, Torbjørn Omland, James McCord, Bertram L. Kasiske and Fulvio Stacul and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Peter A. McCullough

598 papers receiving 35.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Kidney Disease as a Risk Factor for Development of Cardiovascular Disease

2003 2.9k citations Peter A. McCullough et al. Circulation profile →
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure

2002 2.4k citations Alan S. Maisel, Padma Krishnaswamy et al. profile →
Acute Renal Failure After Coronary Intervention

1997 1.3k citations Peter A. McCullough et al. profile →
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease

2003 874 citations Peter A. McCullough et al. profile →
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association

2019 801 citations Claudio Ronco, Peter A. McCullough et al. Circulation profile →
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy

2013 763 citations Peter A. McCullough et al. profile →
The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome

2016 707 citations Peter A. McCullough et al. profile →
B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure

2002 658 citations Peter A. McCullough, Richard M. Nowak et al. Circulation profile →
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

2011 653 citations Kai‐Uwe Eckardt, Peter A. McCullough et al. profile →
Contrast-Induced Acute Kidney Injury

2008 648 citations Peter A. McCullough profile →
Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes

2005 515 citations Peter A. McCullough et al. profile →
Contrast-Induced Acute Kidney Injury

2016 484 citations Peter A. McCullough, Jeffrey Schussler et al. profile →

Peers

Countries citing papers authored by Peter A. McCullough

Since Specialization

Citations

This map shows the geographic impact of Peter A. McCullough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. McCullough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. McCullough more than expected).

Fields of papers citing papers by Peter A. McCullough

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. McCullough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. McCullough. The network helps show where Peter A. McCullough may publish in the future.

Co-authorship network of co-authors of Peter A. McCullough

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. McCullough. A scholar is included among the top collaborators of Peter A. McCullough based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. McCullough. Peter A. McCullough is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association Between COVID-19 Vaccination and Neuropsychiatric Conditions 2025 ·International Journal of Innovative Research in Medical Science ·James A. Thorp, (unknown), Catherine Cosgrove, (unknown), (unknown), (unknown), Peter A. McCullough	0
2	COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2 2024 ·M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, Russ Wolfinger, (unknown), Peter A. McCullough	3
3	RSVpreF vaccination in pregnancy: a meta-analysis of maternal-fetal safety and infant efficacy 2024 ·Obstetrics & Gynecology Science ·Greg Marchand, (unknown), (unknown), Peter A. McCullough	1
4	Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care 2023 ·Biomedicines ·Alberto Palazzuoli, Matteo Beltrami, Peter A. McCullough	5
5	Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Naïve Patients 2023 ·Kidney Medicine ·Wolfgang C. Winkelmayer, Susan Arnold, Steven K. Burke, Glenn M. Chertow, Kai‐Uwe Eckardt, Alan G. Jardine, Eldrin F. Lewis, Wei Luo, Kunihiro Matsushita, Peter A. McCullough, Todd Minga, Patrick S. Parfrey	8
6	Usefulness of Combined Renin-Angiotensin System Inhibitors and Diuretic Treatment In Patients Hospitalized with COVID-19 2022 ·The American Journal of Cardiology ·Alberto Palazzuoli, Kristen M. Tecson, Marco Vicenzi, Fabrizio D’Ascenzo, Gaetano Maria De Ferrari, Silvia Monticone, Gioel Gabrio Secco, Guido Tavazzi, Giovanni B. Forleo, Paolo Severino, Francesco Fedele, Francesco Giuseppe De Rosa, Peter A. McCullough	3
7	Thromboembolic Events with Vadadustat vs. Darbepoetin Alfa for Anemia Treatment in Patients with Dialysis-Dependent CKD 2021 ·Journal of the American Society of Nephrology ·Patrick S. Parfrey, Wei Luo, (unknown), Robert A. Anders, Dennis Vargo, Peter A. McCullough	1
8	Assessment of Thromboembolic Events with Vadadustat vs. Darbepoetin Alfa for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD 2021 ·Journal of the American Society of Nephrology ·Peter A. McCullough, Wei Luo, Robert A. Anders, Dennis Vargo, Patrick S. Parfrey	1
9	Screening, detection, and management of heart failure in the SARS-CoV2 (COVID-19) pandemic 2021 ·Heart Failure Reviews ·Alberto Palazzuoli, Gaetano Ruocco, Kristen M. Tecson, Peter A. McCullough	4
10	The Economic Impact of Mitral Regurgitation on Patients With Medically Managed Heart Failure 2019 ·The American Journal of Cardiology ·Peter A. McCullough, Hirsch Mehta, Colin M. Barker, (unknown), Candace Gunnarsson, Michael P. Ryan, (unknown), (unknown), (unknown), Patrick Verta	1
11	Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular procedures 2018 ·Catheterization and Cardiovascular Interventions ·Peter A. McCullough, Thomas M. Todoran, Emmanouil S. Brilakis, Michael P. Ryan, Candace Gunnarsson	1
12	Missed myocardial infarctions in ED patients prospectively categorized as low risk by established risk scores 2017 ·The American Journal of Emergency Medicine ·Adam J. Singer, Martin Than, Stephen W. Smith, Peter A. McCullough, Tyler W. Barrett, Robert Birkhahn, Michael L. Reed, Henry C. Thode, W. David Arnold, Lori B. Daniels, (unknown), Gary Headden, W. Frank Peacock	23
13	Impact of Enhanced External Counterpulsation on Heart Failure Rehospitalization in Patients With Ischemic Cardiomyopathy 2016 ·The American Journal of Cardiology ·Kristen M. Tecson, Marc A. Silver, (unknown), Clay Cauthen, Michael Kwan, Jeffrey Schussler, Anupama Vasudevan, James A. Watts, Peter A. McCullough	6
14	Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial 2014 ·Critical Care ·Alberto Palazzuoli, Marco Pellegrini, Gaetano Ruocco, Giuseppe Martini, Beatrice Franci, Maria Stella Campagna, (unknown), Ranuccio Nuti, Peter A. McCullough, Claudio Ronco	53
15	Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management 2014 ·Reviews in Cardiovascular Medicine ·Peter A. McCullough, Thomas M. Beaver, Elliott Bennett‐Guerrero, Michael Emmett, Gregg C. Fonarow, Abhinav Goyal, Charles A. Herzog, Mikhail Kosiborod, Biff F. Palmer	56
16	Acute Kidney Injury and Cardiovascular Outcomes in Acute Severe Hypertension 2010 ·Circulation ·Lynda A. Szczech, Christopher B. Granger, Joseph F. Dasta, Alpesh Amin, W. Frank Peacock, Peter A. McCullough, John W. Devlin, Matthew R. Weir, Jason N. Katz, Frederick A. Anderson, Allison Wyman, Joseph Varón	44
17	Uncovering Heart Failure in Patients with a History of Pulmonary Disease: Rationale for the Early Use of B‐type Natriuretic Peptide in the Emergency Department 2003 ·Academic Emergency Medicine ·Peter A. McCullough, Judd E. Hollander, Richard M. Nowak, Alan B. Storrow, Philippe Duc, Torbjørn Omland, James McCord, Howard C. Herrmann, Philippe Gabríel Steg, Arne Westheim, Cathrine Wold Knudsen, William T. Abraham, Sumant Lamba, Alan H.B. Wu, Alberto Perez, Paul Clopton, Padma Krishnaswamy, Radmila Kazanegra, Alan S. Maisel	79
18	Performance of Multiple Cardiac Biomarkers Measured in the Emergency Department in Patients with Chronic Kidney Disease and Chest Pain 2002 ·Academic Emergency Medicine ·Peter A. McCullough, Richard M. Nowak, Craig C. Foreback, Glenn Tokarski, Michael C. Tomlanovich, Nabil Khoury, W. Douglas Weaver, Keisha R. Sandberg, James McCord	16
19	Performance of Multiple Cardiac Biomarkers Measured in the Emergency Department in Patients with Chronic Kidney Disease and Chest Pain 2002 ·Academic Emergency Medicine ·Peter A. McCullough, Richard M. Nowak, Craig C. Foreback, Glenn Tokarski, Michael C. Tomlanovich, Nabil Khoury, W. Douglas Weaver, Keisha R. Sandberg, James McCord	29
20	Underuse of invasive procedures among Medicaid patients with acute myocardial infarction 2001 ·American Journal of Public Health ·(unknown), Peter A. McCullough, Thomas G. DiSalvo, G. William Dec, Paul Jenkins, W. Douglas Weaver	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact